A novel γ-chain mutation p.Asp318His in a Chinese family with dysfibrinogenemia
Authors:
- 24 October 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 35 (8) , 365-371
Abstract
Background: Congenital dysfibrinogenemia is characterized by reduced fibrinogen activity, but normal immunoreactive fibrinogen levels. Here, we present a novel case with an elevated risk of thrombosis. Methods: Coagulation assays, gene analysis, in silico tools, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), fibrin polymerization, thrombin generation assay, and electron microscopy scanning were utilized to elucidate the pathogenic mechanism. Results: The proband manifested with a normal immunologic fibrinogen (2.13 g/l) but reduced functional fibrinogen (0.39 g/l). Subsequent genetic analysis unveiled a novel heterozygous mutation, c.1030G>C (p.Asp318His), in the γ-chain D domain of fibrinogen, which was highly conserved in homologous species and led to enhanced thrombin generation capability. The ability of the proband's fibrinogen to polymerize was significantly impaired, with decreased final turbidity. Scanning electron microscopy indicated that the fibers of the proband were thinner than normal, with smaller pores. Thromboelastography (TEG) results demonstrated prolonged K time, decreased angle value, and a normal confidence interval value in the proband. Conclusion: We present a novel case displaying the γAsp318His mutation, which resulted in dysfibrinogenemia.Keywords
This publication has 18 references indexed in Scilit:
- Fibrinogen and fibrin: synthesis, structure, and function in health and diseaseJournal of Thrombosis and Haemostasis, 2023
- A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited DysfibrinogenemiaHamostaseologie, 2023
- Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous ThrombosisHamostaseologie, 2023
- Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature reviewThrombosis Research, 2022
- Fibrin clot properties to assess the bleeding phenotype in unrelated patients with hypodysfibrinogenemia due to novel fibrinogen mutationsThrombosis Research, 2021
- Fibrinogen Columbus III: A novel c.963del frameshift mutation in the FGG gene resulting in hypofibrinogenemia with a bleeding phenotypePediatric Blood & Cancer, 2020
- Fibrinogen and fibrin: An illustrated reviewResearch and Practice in Thrombosis and Haemostasis, 2019
- Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen DisordersSeminars in Thrombosis and Hemostasis, 2016
- Fibrinogen Hangzhou: Congenital dysfibrinogenemia caused by the novel missense mutation in FGG (γ308Asn→Thr)Clinica Chimica Acta, 2014
- The binding of thrombin by fibrin.Journal of Biological Chemistry, 1979